comparemela.com

Latest Breaking News On - Glenmark pharmaceuticals ltd - Page 3 : comparemela.com

Indices: Stock market update: Nifty Pharma index falls 0.21% in a weak market

The Nifty Pharma index was trading 0.21 per cent down at 19176.85.

India
Bharat
Nagaraj-shetti
Vikas-nigam
Laurus-labs-ltd
Abbott-india-ltd
Technical-research-analyst
Sanofi-india-ltd
Divi-laboratories-ltd
Gland-pharma-ltd
Indian-railway-fin
Biocon-ltd

Indices: Stock market update: Nifty Pharma index falls 0.5%

Indices: Stock market update: Nifty Pharma index falls 0.5%
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

India
Atal-realtech
Indian-railway-fin
Aurobindo-pharma-ltd
Mankind-pharma-ltd
Biocon-ltd
Glenmark-pharmaceuticals-ltd
Divi-laboratories-ltd
Sanofi-india-ltd
Abbott-india-ltd
Lupin-ltd
Inox-wind-ltd

Glenmark Pharma Q4 net loss widens to Rs 1,239 crore

Glenmark Pharma Q4 net loss widens to Rs 1,239 crore
moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.

United-states
India
America
Glenn-saldanha
Equity-share-capital-of-the-company
Glenmark-pharmaceuticals-ltd
Pharmaceuticals-ltd
Equity-share-capital
Annual-general
America-business
Managing-director
Glenmark-pharmaceuticals

Glenmark Pharmaceuticals : Pharma Reports Q4 FY2023-24 Financial results

Glenmark Pharmaceuticals : Pharma Reports Q4 FY2023-24 Financial results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Mumbai
Maharashtra
India
United-states
America
Glenn-saldanha
Glenmark-life-sciences
Glenmark-pharmaceuticals-ltd
Glenmark-pharmaceuticals-limited
Press-release
America-business
Managing-director

Anti-infectives Market Size, Trends and Future Scope Forecast 2023-2033

Anti-infectives Market: by Product (Antibiotics, Antivirals, Antifungals, Others), by Indication (HIV Infection, Pneumonia, Respiratory Virus Infection, Sepsis, Tuberculosis, Others), by Route Of Administration (Oral, Topical, Parenteral, Others), by

Italy
Israel
Egypt
Belgium
Poland
France
Turkey
South-korea
Brazil
Germany
New-zealand
Peru

vimarsana © 2020. All Rights Reserved.